prijava
MOSTAR, October 6 (FENA) – Following reports of adverse reactions after immunization in the Republic of Croatia, the Public Health Institute of the Federation of Bosnia and Herzegovina (PHI FBiH) is temporarily suspending distribution and recommending a temporary suspension of the use of the BCG vaccine produced by Bulgarian manufacturer BB-NCIPD Ltd. in the Federation of Bosnia and Herzegovina as of October 6.
Sadržaj dostupan isključivo pretplatnicima FENA servisa. Za više informacija o načinu i
uslovima korištenja servisa kontaktirajte marketing@fena.ba.
(FENA) S. R.
